Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ASCO

<< Previous

Bullboard Posts

Next >>

Comment by JohnnyYegon May 24, 2024 9:23am

74 Views

Post# 36055552

RE:RE:RE:RE:RE:RE:RE:RE:ASCO

Keep it up Azz!! I logged out just to see what Enemymine has been saying - what a pathetic worm. I hope everyone recognizes what a lack of moral integrity looks like as shown in it (the only pronoun they get). Attacking someone who has second person and a directly relevant perspective to share, and consistently lying about anything to do with stocks. A basher and shorter who conducts itself for simple monetary gain. Sold its soul a long time ago.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals